BCAB
Price
$2.25
Change
-$0.10 (-4.26%)
Updated
Apr 25, 6:59 PM EST
13 days until earnings call
GRTX
Price
$0.21
Change
+$0.03 (+16.67%)
Updated
Apr 25, 6:59 PM EST
18 days until earnings call
Ad is loading...

Compare trend and price BCAB vs GRTX

Header iconBCAB vs GRTX Comparison
Open Charts BCAB vs GRTXBanner chart's image
BioAtla
Price$2.25
Change-$0.10 (-4.26%)
Volume$255.2K
CapitalizationN/A
Galera Therapeutics
Price$0.21
Change+$0.03 (+16.67%)
Volume$439.13K
CapitalizationN/A
View a ticker or compare two or three
BCAB vs GRTX Comparison Chart

Loading...

BCABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GRTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCAB vs. GRTX commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a StrongSell and GRTX is a Hold.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (BCAB: $2.25 vs. GRTX: $0.21)
Brand notoriety: BCAB and GRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 73% vs. GRTX: 28%
Market capitalization -- BCAB: $108.22M vs. GRTX: $11.29M
BCAB [@Biotechnology] is valued at $108.22M. GRTX’s [@Biotechnology] market capitalization is $11.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $562.44B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileGRTX’s FA Score has 1 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • GRTX’s FA Score: 1 green, 4 red.
According to our system of comparison, GRTX is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 5 TA indicator(s) are bullish while GRTX’s TA Score has 6 bullish TA indicator(s).

  • BCAB’s TA Score: 5 bullish, 5 bearish.
  • GRTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GRTX is a better buy in the short-term than BCAB.

Price Growth

BCAB (@Biotechnology) experienced а -7.41% price change this week, while GRTX (@Biotechnology) price change was +11.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.76%. For the same industry, the average monthly price growth was -8.05%, and the average quarterly price growth was +1257.31%.

Reported Earning Dates

BCAB is expected to report earnings on Aug 08, 2024.

GRTX is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (-0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCAB with price predictions.
OPEN
A.I.dvisor published
a Summary for GRTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BCAB($108M) has a higher market cap than GRTX($11.3M). GRTX YTD gains are higher at: 25.653 vs. BCAB (-4.472).
BCABGRTXBCAB / GRTX
Capitalization108M11.3M956%
EBITDAN/AN/A-
Gain YTD-4.47225.653-17%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BCABGRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
BCABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GRTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POAI1.340.05
+3.88%
Predictive Oncology
BEN25.350.02
+0.08%
Franklin Resources
PRQR2.01-0.01
-0.50%
ProQR Therapeutics NV
INN6.27-0.10
-1.57%
Summit Hotel Properties
KSS24.89-0.51
-2.01%
Kohls Corp

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with STRO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+4.91%
STRO - BCAB
47%
Loosely correlated
-6.72%
CYTK - BCAB
43%
Loosely correlated
+1.91%
AXON - BCAB
41%
Loosely correlated
+0.28%
DNLI - BCAB
41%
Loosely correlated
-3.41%
STOK - BCAB
39%
Loosely correlated
+3.64%
More

GRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRTX has been loosely correlated with CALA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GRTX jumps, then CALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRTX
1D Price
Change %
GRTX100%
-5.82%
CALA - GRTX
35%
Loosely correlated
-31.03%
SRZN - GRTX
34%
Loosely correlated
-0.44%
FATE - GRTX
34%
Loosely correlated
-5.29%
SPRC - GRTX
33%
Loosely correlated
-1.63%
AMRN - GRTX
33%
Poorly correlated
-0.53%
More